What: Amid growing interest in testosterone for treating various menopausal symptoms—from mood improvement to increased libido—experts urge caution.
Key line: [Details not provided].
Source: New York Times.
Luxury spa resort launches new “Inner Glow” retreat focused on hormone health and long-term wellness.
Makary says he won’t act on mifepristone for now, but is “awaiting more data.”
Meghan Markle discusses rare and life-threatening postpartum condition on new podcast.
A major study ties maternal diabetes to neurodevelopmental issues in children.
A former NIH director calls for institutional changes to better prioritize female health.
ADF targets birth control and IUD coverage in campaign to cut ties with ACOG.
Bladder-leak brand Poise proposes using pads for hormone testing in rural areas.
WHI funding restored after backlash; $140 saved for every dollar spent, researchers say.
Maternie’s live tracker outlines federal program cuts, including Title X and IVF teams.
Bladder-leak brand Poise proposes using pads for hormone testing in rural areas.
Cosmo breaks down Botox alternatives—and why your injector matters most.
Even with dye bans, ultra-processed food remains the real issue, The Atlantic argues.
A study finds women with incontinence are more likely to have heart disease risk factors.
Ashley Parker writes about the emotional and medical realities of miscarriage, including how the term “abortion” appears in routine procedures.
JAMA editorial calls for uniform lactation training among healthcare workers.
The influential Women’s Health Initiative will shut down without federal support.
NWLC report warns that birth control access is increasingly under threat post-Roe.
Most menopause-marketed products are rebranded basics—at luxury prices, says Women’s Health investigation.
ADF targets birth control and IUD coverage in campaign to cut ties with ACOG.
Study finds no added benefit from multi-drug regimens for women with heart pain but no artery blockage.